Form 4: Arteris COO Sells Shares for Tax Obligations and Under Pre-Arranged Plan
Insider Trading Report
Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, reported the sale of 6,258 shares of common stock in early July 2025, primarily to cover tax liabilities from restricted stock unit releases and through a pre-arranged 10b5-1 trading plan.
Summary
- Laurent R. Moll, Chief Operating Officer of Arteris, Inc. (AIP), reported multiple sales of the company's common stock.
- On July 2, 2025, a total of 4,704 shares were sold at a price of $8.9924 per share.
- These sales on July 2, 2025, were conducted to satisfy the Reporting Person's tax liability arising from the release of restricted stock units.
- On July 3, 2025, an additional 1,554 shares were sold at a weighted average price of $9.2292 per share, with individual transaction prices ranging from $9.15 to $9.35.
- The transaction on July 3, 2025, was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Moll on March 12, 2025.
- Following these transactions, Mr. Moll beneficially owns 477,207 shares of Arteris, Inc. common stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider sales reduce ownership, the stated reasons (tax obligations from RSU release and a pre-arranged 10b5-1 plan) indicate routine, non-discretionary transactions rather than a lack of confidence in the company's future. This mitigates potential negative interpretations.
Positives
- The sales were primarily for routine purposes, including satisfying tax liabilities from restricted stock unit releases and executing a pre-arranged 10b5-1 trading plan, which indicates a structured approach to insider transactions rather than a discretionary sale based on new negative information.
Negatives
- The transactions represent a reduction in the Chief Operating Officer's direct beneficial ownership of Arteris, Inc. common stock by 6,258 shares.
Risks
- Insider sales, even for routine reasons, can sometimes be perceived negatively by the market, potentially leading to short-term downward pressure on the stock price.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.
Industry Context
This Form 4 filing, detailing insider stock sales, is a routine disclosure and does not provide specific insights into broader industry trends or competitive dynamics within the semiconductor IP or electronic design automation sectors where Arteris operates.
Related Party Transactions
- The reported transactions are sales of common stock by a Chief Operating Officer, which are considered insider transactions.
Stakeholder Impact
- Shareholders: The reduction in insider ownership, while routine, might be noted by investors. However, the structured nature of the sales (tax, 10b5-1 plan) typically lessens concerns about management's confidence.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date the 10b5-1 trading plan was adopted by Laurent R. Moll. |
| 07/02/2025 | Date of sales totaling 4,704 shares to satisfy tax liability from RSU release. |
| 07/03/2025 | Date of sale of 1,554 shares under a 10b5-1 trading plan. |
| 07/07/2025 | Date the Form 4 filing was signed. |
Keywords
Arteris, AIP, insider trading, Form 4, stock sale, beneficial ownership, 10b5-1 plan, restricted stock units, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.